The Firmwatch take
Frontier Biopharma Limited is a 5-year-old finance and insurance, active on the Companies House register. The latest filed accounts (year to 31 December 2024) show GBP 11m in net assets, with no distress signals detected. No insolvency or strike-off filings appear in our public Companies House and Gazette data.
Refreshed 24 May 2026
Incorporated
20 January 2021
5 years on the register
Sector
Activities of production holding companies
SIC 64202
Size
Not classified
Net assets
£11m
Top 10% in sector
Cash at bank
Not disclosed
Not required for this filing type
Latest filing
None yet
Insolvency risk
Low insolvency risk
The latest public accounts do not show obvious balance-sheet stress. This does not rule out trading problems, but the filed numbers look comparatively steady.
Positive net assets
The latest extracted accounts show assets exceeding liabilities.
Sector benchmark · Finance and Insurance
How this company compares in 38,253 filers in this sector
Top 10% in sector — Frontier Biopharma Limited shows £11m in net assets. Sector median is £2k.
Sector medians are computed annually across all UK companies in this broad sector. Position is approximate — see the Money tab for the full balance sheet.
Address pattern · RG41 5TS
528 other UK companies registered at this postcode.
Active
477
Dissolved
35
Strike-off action
15
Money
What the balance sheet says
Net assets
£11m
Top 10% in sector · sector median £2k · 38,253 filers in this sector
Cash
Not disclosed
Working cap.
£818k
Median £9k
Current ratio
—
Signals · 1
Positive net assets
The latest filed accounts show assets exceeding liabilities.
People
Who runs this company
- KS
KAYE, Steven Jonathan
director · since 2021
Registered office
Address intelligence
528 other companies use this address.
High-volume registered-office service. Many UK companies use these legitimately, but they are also a known hosting location for shell entities. Treat this as a flag, not a verdict.
Firmwatch turns UK Companies House filings into plain-English company intelligence. Data is refreshed daily; signals are generated from public balance-sheet and filing patterns.